SCHEMBL31468367

SCHEMBL31468367

N#Cc1cccc(-c2nc(-c3ccccc3F)c3sccn23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 6/20 0.47
GABRB3 P28472 6/20 0.47
GABRA3 P34903 6/20 0.47
GABRA5 P31644 5/20 0.47
ADORA2A P29274 5/20 0.38
ADORA1 P30542 4/20 0.38
ADRA2C P18825 1/20 0.37
MAOB P27338 1/20 0.37
GABRA1 P14867 2/20 0.37
ENPP1 P22413 1/20 0.36
ADORA2B P29275 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
F11 P03951 1/20 0.35
GRM5 P41594 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31468378 0.88 TNK2 (0.39) GABRG2GABRB3GABRA3GABRA5ADORA2A
SCHEMBL31468344 0.87 ENPP1 (0.39) GABRG2GABRB3GABRA3GABRA5ADORA2A
SCHEMBL31468332 0.84 ADORA2A (0.41) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL31468426 0.83 SMN1; SMN2 (0.44) ADORA2AADORA1MAOBADORA2BHSD17B10
SCHEMBL31468308 0.82 NR1I3 (0.37) GABRG2GABRB3GABRA3GABRA5GABRA1
SCHEMBL31468331 0.80 MAOA (0.49) HSD17B10
SCHEMBL31468365 0.78 F11 (0.40) GABRG2GABRB3GABRA3GABRA5ADORA2A
SCHEMBL31468294 0.77 NR1I3 (0.39) ENPP1GRM5
SCHEMBL31468303 0.75 NR1I3 (0.39) GABRG2GABRB3GABRA3GABRA5ADORA2A
SCHEMBL31468305 0.74 TNK2 (0.47) GABRG2GABRB3GABRA3GABRA5GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064210-A1 INHIBITORS OF BILIVERDIN REDUCTASE B (BLVRB) BLOOD CELL TECHNOLOGIES, LLC (US) 2025-03-27 WO disclosed